Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 36-Month Results of DETOUR2 Study at 2024 VIVA Late-Breaking Clinical Trial Session

See Release

All News

Archives

Endologix Provides an Update on the Nellix® Endovascular Aneurysm Sealing System U.S. Regulatory Status

Endologix Enters into $170 Million Credit Facility with Deerfield Management

Endologix LLC Announces Enrollment of First Patients in ELEVATE IDE Clinical Study

In Memoriam of Dr. Ted Diethrich 1935-2017

Endologix Completes Patient Enrollment in the Ovation(R) LUCY Study First Prospective Study Evaluating EVAR in a Female Population